Investor Capital Point Ltd.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Capital Point Ltd. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-20 13G NSRX / Nasus Pharma Ltd. 575,129
2022-02-14 13G/A ENTX / Entera Bio Ltd. 1,147,385 0
2021-02-16 13G/A ENTX / Entera Bio Ltd. 1,604,820 1,147,385
2020-12-10 13G/A NMTR / 9 Meters Biopharma Inc 7,378,059 7,295,893
2020-09-03 13G NMTR / 9 Meters Biopharma Inc 7,378,059
2020-02-13 13G/A ENTX / Entera Bio Ltd. 1,151,806 1,604,820
2019-10-24 13D/A CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) 12,844,020 5,509,260
2019-10-17 13D/A CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) 12,844,020 12,844,020
2019-09-11 13D/A CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) 12,844,020 12,844,020
2019-08-08 13D/A CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) 12,844,020 12,844,020
2019-07-10 13D/A CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) 11,971,020 12,844,020
2019-06-14 13D/A CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) 11,971,020 11,971,020
2019-06-06 13D/A CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) 10,352,430 11,971,020
2019-05-30 13D CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) 10,352,430
2019-02-14 13G ENTX / Entera Bio Ltd. 1,151,806
2016-03-07 13G/A NDRM / NeuroDerm Ltd. 1,545,622 787,312
2015-09-17 13G/A NDRM / NeuroDerm Ltd. 1,545,622
2015-02-17 13G CCU / Compañía Cervecerías Unidas S.A. - Depositary Receipt (Common Stock) 2,090,480